Stability studies are an essential part of the drug development process in the pharmaceutical industry. They are conducted to evaluate the quality, efficacy, and safety of drugs over time. Stability studies help pharmaceutical companies ensure that their products remain effective and safe for patients throughout their shelf life. In this article, we will discuss the importance of stability studies, the types of stability studies, and the regulatory requirements for stability testing.
Why Are Stability Studies Important?
- Stability studies are important for several reasons. Firstly, they help pharmaceutical companies ensure that their products remain effective and safe for patients over time. Drugs can degrade over time, which can affect their safety and efficacy.
- Stability studies help identify the degradation products and establish their impact on the drug's safety and efficacy.
- Secondly, stability studies are required by regulatory agencies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to obtain approval for the commercialization of a drug. Stability data must be submitted to regulatory agencies to demonstrate the safety and efficacy of a drug.
Types of Stability Studies
There are several types of stability studies that can be conducted during drug development. The most common types are as follows:
- Real-time stability studies: Real-time stability studies are conducted over an extended period, usually three years, to evaluate the stability of a drug under recommended storage conditions.
- Accelerated stability studies: Accelerated stability studies are conducted at higher temperatures and humidity levels than recommended storage conditions to simulate the effects of long-term storage in a short period. Accelerated stability studies are typically conducted for six months.
- Photostability studies: Photostability studies are conducted to evaluate the stability of a drug when exposed to light. Photostability studies are typically conducted for three to six months.
- Forced degradation studies: Forced degradation studies are conducted to evaluate the stability of a drug under stressful conditions. The purpose of forced degradation studies is to identify degradation products and establish their impact on the drug's safety and efficacy.
Regulatory Requirements for Stability Testing
Regulatory agencies such as the FDA and EMA have established guidelines for stability testing. The guidelines specify the testing requirements, including the number of batches to be tested, the storage conditions, the test duration, and the analytical methods to be used. The guidelines also specify the data that must be submitted to regulatory agencies.
The FDA's stability testing guidelines require the following:
- Testing of three batches of the drug product
- Testing under recommended storage conditions and, if applicable, under stress conditions
- Testing at predetermined time intervals
- Analytical methods must be validated
- Data must be submitted to the FDA as part of the new drug application (NDA)
The EMA's stability testing guidelines require the following:
- Testing of three batches of the drug product
- Testing under recommended storage conditions and, if applicable, under stress conditions
- Testing at predetermined time intervals
- Analytical methods must be validated
- Data must be submitted to the EMA as part of the marketing authorization application (MAA).
ALSO READ: Interview Questions for Microbiologists
What is Stability?
The term “stability” with respect to a drug dosage form, refers to the physical and chemical integrity of the dosage unit. When appropriate, the ability of the dosage unit to maintain protection against microbial contamination.
What are the factors, which affect the stability of a drug?
The stability parameters of a drug dosage form can be influenced by environmental conditions of storage (temperature, light, air & humidity) as well as packaging components.
What is the shelf life/expiration period?
The time period during which a drug substance or drug product is expected to remain within the approved shelf-life specification provided that it is stored under the conditions defined on the container label.
What is the purpose of the stability study?
- Provide evidence, as to how the quality of the drug product varies with time.
- Establish shelf life for the product.
- To recommend storage conditions
- To determine container suitability.
What is accelerated stability testing?
Studies designed to increase the rate of chemical degradation or physical change of a drug substance or drug product by using exaggerated storage conditions as part of the formal stability studies. Data from these studies, in addition to long-term stability studies, can be used to assess longer-term chemical effects at non-accelerated conditions and to evaluate the effect of short-term excursions outside the label storage conditions such as might occur during shipping.
What are climatic zones in stability testing?
The four zones in the world are distinguished by their characteristic prevalent annual climatic conditions. This is based on the concept described by W. Grimm.
Type of Climate Zone
Zone I: Temperate zone
Zone II: Mediterranean/subtropical zone
Zone III: Hot dry zone
Zone IVa: Hot humid/tropical zone
Zone IVb: Hot/very humid (ASEAN testing conditions)
What is the testing frequency for an accelerated stability study?
At the accelerated storage condition, a minimum of three-time points, including the initial and final time points (e.g., 0, 3, and 6 months), from a 6-month study is recommended. Where an expectation (based on development experience) exists that results from accelerated studies are likely to approach significant change criteria, increased testing should be conducted either by adding samples at the final time point or by including a fourth-time point in the study design.
What is the testing frequency for long-term (drug product) stability studies?
The recommended frequency of testing at the long-term storage condition is normally every 3 months over the first year, every 6 months over the second year, and annually thereafter through the proposed shelf life.
What are bracketing & matrixing in stability study?
Bracketing & matrixing are reduced designs, where the testing frequency is reduced or certain factor combinations are not tested at all.
What is a “significant change” for drug products?
In general, “significant change” for a drug product is defined as:
- A 5% change in assay from its initial value; or failure to meet the acceptance criteria for potency when using biological or immunological procedures;
- Any degradation product exceeding its acceptance criterion;
- Failure to meet the acceptance criteria for appearance, physical attributes, and functionality test (e.g., color, phase separation, resuspendibility, caking, hardness, dose delivery per actuation)
- Failure to meet the acceptance criterion for pH; or
- Failure to meet the acceptance criteria for dissolution for 12 dosage units.
